ESPEN 成人慢性肠衰竭临床指南。
ESPEN guidelines on chronic intestinal failure in adults.
机构信息
Center for Chronic Intestinal Failure, Department of Digestive System, St. Orsola-Malpighi University Hospital, Bologna, Italy.
Department of Medicine, Oncology and Hematology, University of Freiburg, Germany.
出版信息
Clin Nutr. 2016 Apr;35(2):247-307. doi: 10.1016/j.clnu.2016.01.020. Epub 2016 Feb 8.
BACKGROUND & AIMS: Chronic Intestinal Failure (CIF) is the long-lasting reduction of gut function, below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth. CIF is the rarest organ failure. Home parenteral nutrition (HPN) is the primary treatment for CIF. No guidelines (GLs) have been developed that address the global management of CIF. These GLs have been devised to generate comprehensive recommendations for safe and effective management of adult patients with CIF.
METHODS
The GLs were developed by the Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. The GRADE system was used for assigning strength of evidence. Recommendations were discussed, submitted to Delphi rounds, and accepted in an online survey of ESPEN members.
RESULTS
The following topics were addressed: management of HPN; parenteral nutrition formulation; intestinal rehabilitation, medical therapies, and non-transplant surgery, for short bowel syndrome, chronic intestinal pseudo-obstruction, and radiation enteritis; intestinal transplantation; prevention/treatment of CVC-related infection, CVC-related occlusion/thrombosis; intestinal failure-associated liver disease, gallbladder sludge and stones, renal failure and metabolic bone disease. Literature search provided 623 full papers. Only 12% were controlled studies or meta-analyses. A total of 112 recommendations are given: grade of evidence, very low for 51%, low for 39%, moderate for 8%, and high for 2%; strength of recommendation: strong for 63%, weak for 37%.
CONCLUSIONS
CIF management requires complex technologies, multidisciplinary and multiprofessional activity, and expertise to care for both the underlying gastrointestinal disease and to provide HPN support. The rarity of the condition impairs the development of RCTs. As a consequence, most of the recommendations have a low or very low grade of evidence. However, two-thirds of the recommendations are considered strong. Specialized management and organization underpin these recommendations.
背景与目的
慢性肠道衰竭(CIF)是指肠道功能长期下降,无法满足吸收宏量营养素和/或水和电解质的最低需求,因此需要静脉补充来维持健康和/或生长。CIF 是最罕见的器官衰竭。家庭肠外营养(HPN)是治疗 CIF 的主要方法。目前尚无针对 CIF 全球管理的指南(GLs)。这些 GL 旨在为成人 CIF 患者的安全有效管理提供全面建议。
方法
GL 由 ESPEN 家庭人工营养和慢性肠道衰竭特别兴趣小组制定。使用 GRADE 系统对证据强度进行评估。建议经过讨论、提交 Delphi 轮次,并在 ESPEN 成员的在线调查中接受。
结果
本 GL 涵盖了以下主题:HPN 的管理;肠外营养配方;短肠综合征、慢性肠道假性梗阻和放射性肠炎的肠道康复、药物治疗和非移植手术;肠道移植;CVC 相关感染、CVC 相关阻塞/血栓形成的预防/治疗;肠道衰竭相关肝病、胆囊泥沙样结石、肾衰竭和代谢性骨病。文献检索提供了 623 篇全文。仅有 12%为对照研究或荟萃分析。共给出 112 条建议:证据等级,51%极低,39%低,8%中,2%高;推荐强度:63%强,37%弱。
结论
CIF 管理需要复杂的技术、多学科和多专业活动以及专业知识,以治疗潜在的胃肠道疾病并提供 HPN 支持。该疾病的罕见性会影响 RCT 的开展。因此,大多数建议的证据等级较低或极低。但是,三分之二的建议被认为是强有力的。专业化的管理和组织是这些建议的基础。